NCT05392946 2026-04-21Iberdomide, Daratumumab, Bortezomib, and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma, IDEAL StudyMayo ClinicPhase 1/2 Active not recruiting49 enrolled
NCT04776395 2026-04-17Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple MyelomaEmory UniversityPhase 2 Recruiting68 enrolled
NCT05434689 2026-04-15COMMANDERUniversity of Alabama at BirminghamPhase 1/2 Active not recruiting80 enrolled